Articles about Product Safety

...

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm Before Lead Plaintiff Deadline on November 3, 2026

Today 13:00 EDT

Via NewMediaWire

Institutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You? ↗

Today 12:20 EDT

Via The Motley Fool

Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to Contact the Firm to Learn About Their Legal Rights

Today 10:45 EDT

Via NewMediaWire

FDA Pauses New Enrollment for Biohaven Epilepsy Drug Program ↗

Today 10:43 EDT

Via Benzinga

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance

Today 10:05 EDT

Via Investor Brand Network

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026

Today 9:15 EDT

Via NewMediaWire

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance

Today 9:05 EDT

Via Investor Brand Network

Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action Deadline - Contact the Firm Before November 3, 2026

Today 9:00 EDT

Via NewMediaWire

Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP ↗

Today 7:02 EDT

Via MarketBeat

3 Quality Compounders with Impressive Fundamentals

Today 0:37 EDT

Via StockStory

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights

September 09, 2026

Via NewMediaWire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026

September 09, 2026

Via NewMediaWire

FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Neurotoxin TrenibotE; Spokane dermatologist Dr. Philip Werschler on What the Letter Means ↗

September 09, 2026

Via Talk Markets

What Running Dozens of Simultaneous Clinical Trials Revealed About How Medicine Actually Gets Made: Dr. Phil Werschler on the Research Behind the Results ↗

September 09, 2026

Via Talk Markets

Nova Warranty Addresses Coverage Gaps for Mercedes-Benz Owners Following Largest Recall Year

September 09, 2026

Via Press Advantage

Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice

September 09, 2026

Via PRLog

Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations

September 09, 2026

Via NewMediaWire

Gene Therapy at Lower Dose Shows Vision Improvements, Opus Genetics Says ↗

September 09, 2026

Via Benzinga

Kaplan Fox Alerts Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors to an Ongoing Investigation Into Possible Securities Law Violations

September 09, 2026

Via NewMediaWire

BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Editorial Following FDA Clearance for Lucid-MS Phase 2 Trial

September 09, 2026

Via Investor Brand Network

BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial Following FDA Clearance for Lucid-MS Phase 2 Trial

September 09, 2026

Via Investor Brand Network

Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market ↗

September 09, 2026

Via Benzinga

Lovegra 100 mg (Sildenafil): Safety, Risks & Medical Guidance ↗

September 09, 2026

Via Talk Markets

Vinod Khosla Calls on FDA to Certify AI That Outperforms the 'Median Human Doctor' ↗

September 09, 2026

Via Benzinga

Companion Diagnostics Market Size, Trends, and Growth Analysis 2026-2033 ↗

September 09, 2026

Via Talk Markets

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026

September 08, 2026

Via NewMediaWire

San Diego Probation Violations Attorney: Criminal Defense Law Services Announced

September 08, 2026

Via Press Release Distribution Service

Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026

September 08, 2026

Via NewMediaWire

Astrazeneca Secures FDA Approval for New Breast Cancer Treatment ↗

September 08, 2026

Via Benzinga

Where Will CRISPR Therapeutics Stock Be in 5 Years? ↗

September 08, 2026

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.